Marijuana industry investment trust Advanced Flower Capital, also referred to as AFC Gamma, is preparing a short general public providing regarding the Nasdaq change that’s designed to raise $94.4 million to $105.6 million.
The providing would include the purchase of 5,555,555 stocks of typical stock in AFC Gamma, or approximately 47% of all of the company’s common stock, at a high price of $17-$19 per share, in accordance with a prospectus dated Feb. 2.
An over-allotment option would offer to 833,333 shares that are additional
“because of the money constrained cannabis market which will not routinely have usage of old-fashioned bank funding and faces restrictions on accessing equity areas, we think we’re well placed to be a prudent financing source to established cannabis industry operators offered our strict underwriting requirements, size and scale of operations and institutional infrastructure,” AFC Gamma noted within the prospectus.
The business had approximately $92.5 million in outstanding loans to eight borrowers at the time of Dec. 26, with commitments “to more or less $19.8 million in extra loans and commitments from current loans, with more or less $485.2 million of possible loans earnestly under review inside our pipeline,” based on the prospectus.
AFC Gamma expects to web roughly $91 million through the IPO, or just as much as $105 million in the event that over-allotment choice is completely exercised, centered on an $18 IPO cost.
The business would utilize the profits to settle borrowings that are outstanding fund its current $19.8 million loan commitments and originate new loans as well as for working capital and other general corporate purposes.
AFC Gamma raised $80 million for loans August that is last loaned $22 million to Pennsylvania-based natural treatments in November.
The company’s proposed Nasdaq expression will be AFCG.